Accelerated testing by French certification body Certisolis finds wide performance divergence and design vulnerabilities in ...
A pair of well-known marijuana compounds work in tandem to target ovarian cancer cells In A Nutshell CBD and THC killed ...
BillionToOne saw rapid growth in molecular diagnostics, strong Q3 results, and evolving valuation. Read here for more ...
The 1995 discovery of regulatory T cells underpins newer investigations pointing to potential allergy treatments and ...
From vitamin C to your microbiome and mindset, the latest science of immunity is often counterintuitive. Here's how to give ...
A recently approved antibody drug from Regeneron Pharmaceuticals eradicates residual traces of multiple myeloma after initial ...
Pathophysiologic biomarkers for chronic spontaneous urticaria (CSU) are emerging, which can help better target therapies for ...
Even beyond the pendulum lurches between presidencies, many of the perennial debates over education policy, politics, and ...
First data reported from non-MTS and bilateral MTLE subjects demonstrate robust seizure reduction - LOW DOSE COHORT: 89% median reduction in disabling seizures for unilateral subjects with MTS at the ...
The loss of domvanalimab is the latest in a string of high-profile failures recorded across the biopharma world for the TIGIT ...
The test, a cell-free DNA test, uses a sample of the mother's blood to screen for certain conditions in the developing fetus ...
MIT scientists have achieved the first-ever lab synthesis of verticillin A, a complex fungal compound discovered in 1970. Its delicate structure stalled chemists for decades, despite differing from ...